AboutContactTerms & Privacy
© 2024 Coverager
All Rights Reserved

erytech

Clinical-stage biopharmaceutical company for rare forms of cancer and orphan diseases.

Headquarters
Lyon, Rhone-Alpes, France
Founded
2004
Operating Status
Active
Ownership Type
Business Model
Links
Number of funding rounds 15
Number of investors 11
Total funding amount $227.52M
Date Amount Stage Investors

Clients Only Feature

Client? Sign in to access this feature.
Not a client? Learn more about Coverager Research.
Company Date Price Percentage URL Notes LOB

Clients Only Feature

Client? Sign in to access this feature.
Not a client? Learn more about Coverager Research.